Rathbones Group PLC Acquires 38,939 Shares of Colgate-Palmolive Company $CL

Rathbones Group PLC grew its holdings in Colgate-Palmolive Company (NYSE:CL) by 22.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 214,516 shares of the company’s stock after purchasing an additional 38,939 shares during the period. Rathbones Group PLC’s holdings in Colgate-Palmolive were worth $16,951,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Quilter Plc increased its holdings in shares of Colgate-Palmolive by 5.7% in the 4th quarter. Quilter Plc now owns 38,989 shares of the company’s stock worth $3,081,000 after purchasing an additional 2,118 shares in the last quarter. Leo Wealth LLC increased its holdings in shares of Colgate-Palmolive by 10.6% in the 4th quarter. Leo Wealth LLC now owns 11,575 shares of the company’s stock worth $915,000 after purchasing an additional 1,111 shares in the last quarter. Sowell Financial Services LLC increased its holdings in shares of Colgate-Palmolive by 5.3% in the 4th quarter. Sowell Financial Services LLC now owns 5,419 shares of the company’s stock worth $428,000 after purchasing an additional 272 shares in the last quarter. Signaturefd LLC increased its holdings in shares of Colgate-Palmolive by 15.8% in the 4th quarter. Signaturefd LLC now owns 15,978 shares of the company’s stock worth $1,263,000 after purchasing an additional 2,181 shares in the last quarter. Finally, eCIO Inc. bought a new stake in shares of Colgate-Palmolive in the 4th quarter worth $75,000. Institutional investors own 80.41% of the company’s stock.

Wall Street Analyst Weigh In

CL has been the topic of a number of research reports. Citigroup raised their price target on Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a research note on Monday, February 2nd. Evercore raised their price target on Colgate-Palmolive from $94.00 to $100.00 and gave the stock an “outperform” rating in a research note on Monday, February 2nd. Morgan Stanley raised their price target on Colgate-Palmolive from $87.00 to $100.00 and gave the stock an “overweight” rating in a research note on Monday, February 2nd. Barclays raised their price target on Colgate-Palmolive from $83.00 to $88.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 3rd. Finally, Royal Bank Of Canada upgraded Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price target on the stock in a research note on Tuesday, December 9th. Eleven investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $95.19.

Colgate-Palmolive Stock Performance

CL stock opened at $84.57 on Tuesday. The company has a market cap of $67.85 billion, a P/E ratio of 32.28, a price-to-earnings-growth ratio of 3.91 and a beta of 0.34. The company has a debt-to-equity ratio of 18.82, a current ratio of 0.83 and a quick ratio of 0.54. The stock’s fifty day moving average price is $91.08 and its 200-day moving average price is $83.49. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $99.33.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, beating the consensus estimate of $0.91 by $0.04. The company had revenue of $5.23 billion for the quarter, compared to the consensus estimate of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.Colgate-Palmolive’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period in the previous year, the business earned $0.91 earnings per share. On average, equities analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Monday, April 20th will be given a dividend of $0.53 per share. This represents a $2.12 annualized dividend and a yield of 2.5%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.52. The ex-dividend date is Monday, April 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 80.92%.

Insider Buying and Selling

In related news, COO Panagiotis Tsourapas sold 35,000 shares of Colgate-Palmolive stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $94.61, for a total transaction of $3,311,350.00. Following the transaction, the chief operating officer directly owned 10,415 shares in the company, valued at approximately $985,363.15. The trade was a 77.07% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Sally Massey sold 15,851 shares of Colgate-Palmolive stock in a transaction on Thursday, February 5th. The shares were sold at an average price of $95.03, for a total value of $1,506,320.53. Following the transaction, the insider owned 13,751 shares in the company, valued at $1,306,757.53. This trade represents a 53.55% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 184,683 shares of company stock valued at $17,486,693 over the last three months. 0.34% of the stock is currently owned by company insiders.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.